ÐÓ°ÉÔ­´´

Skin Analytics has strong potential with its AI-powered melanoma skin cancer screening. Based in London, its B2B SaaS model offers advantages over traditional dermatologist visits and manual skin exams. By using advanced AI, Skin Analytics can provide faster and potentially more accurate diagnoses, addressing delayed detection issues that can increase cancer risks and treatment costs. This positions the company as a key player in the health tech sector, promising efficiency and effectiveness in melanoma detection. With backing from investors like Hoxton Ventures, Skin Analytics has the resources to expand its impact.